openPR Logo
Press release

US CNS Disorders Drug Pipeline Insight 2014

06-30-2017 08:28 AM CET | Health & Medicine

Press release from: PNS Pharma

The Central Nervous System (CNS) disorders market in US is one of the largest segments of pharmaceuticals industry. In US, the numbers of CNS disorders have increased at an alarming rate, while the available therapies were unable to meet the market requirements. There has been steady to rapid growth in the market for CNS disorder, especially over the past two decades. The market for CNS therapies is one of the largest therapeutic categories and also one of the fastest growing. US account for more than 55% of the global CNS Disorders drugs market.

Within the CNS market, the biggest therapeutic area is the market for anti-psychotics, followed by anti-depressive and mood stab markets. Anti-epileptic and anti-Alzheimer’s markets come next while other classes of drugs have a marginal share. Antipsychotics have a market share of nearly 30% while antidepressants corner about 25% of the market. Anti convulsants have about 17% of the market share while drugs used in Alzheimer's Disease form about 9% of the market, with ADHD and narcolepsy drugs medications have about 7% market share. The other classes of drugs have market shares of less than 5% each.

Download Report:

http://www.pnspharma.com/buy-report.php?reporttitle=US-CNS-Disorders-Drug-Pipeline-Insight-2014

New technology including advancements in stem cell therapy and of nanotechnology is expected to drive the growth of the CNS market. Nanotechnology in the form of the nanomaterials for wound care, drug delivery and immunomodulation is specifically seen as a positive influence on CNS therapy that is expected to open growth opportunities. While each of these therapeutic subcategories are served by established treatments there are certain markets segments with significant unmet medical needs still remain, indicating potential in these areas. There are newer treatment methodologies under development such as that using stem cell therapy and of nanotechnology that seek to address these opportunities.

The rapid advances in the R&D segment, many novel drugs are currently available for the treatment of CNS disorders. Industry related to CNS drug delivery system has also got a boost due to rapid advancement of CNS disorders market. Given the magnitude of number of patients and demand for better drugs is going to push pharmaceutical companies for significant investments. Changing life-style is one the main contributor of CNS disorders in US. Increased longevity and ageing population along with launch of novel drugs will drive the growth of CNS disease market in future.

“US CNS Disorders Drug Pipeline Insight 2014” Report Highlight:

* Market Overview & Incidence by Disease
* CNS Disorder Market Dynamics
* CNS Disorder Pipeline by disease, Phase & Company
* CNS Disorder Pipeline: 1083 Drugs in Pipeline
* Majority CNS Drugs in Preclinical Phase: 396 Drugs
* Majority CNS Drugs for Neurodegenerative Disorders: 228 Drugs in Pipeline
* CNS Disorder Market Drugs: 109 Drugs
* Majority CNS Drugs Marketed for Epilepsy: 24 Drugs

For Report Sample Contact: rajesh@pnspharma.com or :Visit :
https://www.pnspharma.com

Recent Publication

* Global Peptide Therapeutics Market & Clinical Trials Insight
* Global Orphan Drug Clinical Pipeline Insight 2022

PNS Pharma is a pioneer in offering exclusive research reports for the pharmaceuticals industry. PNS Pharma offers Syndicated Research Reports on Drug Pipeline and Company Pipeline Analysis. These reports include comprehensive information related to the development of various drugs across clinical pipeline. Further, the reports include details on the originator, Owner, License, Chemical Formula, Patent Information, Phase of development, and Phase of development by country for each specific drug. The reports on company pipeline include all the drugs developed by particular companies across different therapeutic segments and phases and in different countries.

Rajesh Arora
rajesh@pnspharma.com
PNS Pharma
8-9, Ansal Building
Dr. Mukherjee Nagar
Delhi, India

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release US CNS Disorders Drug Pipeline Insight 2014 here

News-ID: 603103 • Views:

More Releases from PNS Pharma

Global Gene Therapy Market Opportunity By Clinical Trials Pipeline sales Kymriah …
"Global Gene Therapy Market Opportunity & Clinical Trials Insight 2026" Report Highlight: o Global Gene Therapy Market Opportunity: > US$ 8 Billion o Global Gene Therapy Clinical Pipeline: > 1000 Therapies In Clinical Trials o Commercially Available Gene Therapies: 11 o USA Dominates Global Gene Therapy Pipeline: > 500 Therapies In Clinical Trials o Cancer Accounts For 50% of Global Gene Therapy Trials Download Report: https://www.pnspharma.com/buy-report.php?reporttitle=Global-Gene-Therapy-Market-Opportunity-%26-Clinical-Trials-Insight-2026 Over the years, gene therapy has been highly responsible for decreasing the mortality rate
Global Orphan Drug Market Clinical Trials Pipeline Report Market Study 2026
"Global Orphan Drug Clinical Trials, Patent & Guidelines Insight 2026" Report Highlights: o Global Orphan Drug Market Opportunity: US$ 300 Billion o US Dominates Global Orphan Drug Market: 50% Market Share o US Orphan Drug Opportunity To Surpass: US$ 150 Billion o Global Orphan Drug Clinical Insight: More Than 900 Drugs o Clinical Insight on Marketed Orphan Drugs: More Than 400 Drugs o Oncology To Dominate Orphan Drug Development: 35% Share o FDA & EMA Regulations For Orphan Drugs o Orphan Drug Designation Criteria
Global Rare Disease Drug Market Opportunity To Surpass US$ 300 Billion By 2026
"Global Orphan Drug Clinical Trials, Patent & Guidelines Insight 2026" Report Highlights: o Global Orphan Drug Market Opportunity: US$ 300 Billion o US Dominates Global Orphan Drug Market: 50% Market Share o US Orphan Drug Opportunity To Surpass: US$ 150 Billion o Global Orphan Drug Clinical Insight: More Than 900 Drugs o Clinical Insight on Marketed Orphan Drugs: More Than 400 Drugs o Oncology To Dominate Orphan Drug Development: 35% Share o FDA & EMA Regulations For Orphan Drugs o Orphan Drug Designation Criteria
Global Orphan Drug Market Opportunity To Surpass US$ 300 Billion By 2026
"Global Orphan Drug Clinical Trials, Patent & Guidelines Insight 2026" Report Highlights: o Global Orphan Drug Market Opportunity: US$ 300 Billion o US Dominates Global Orphan Drug Market: 50% Market Share o US Orphan Drug Opportunity To Surpass: US$ 150 Billion o Global Orphan Drug Clinical Insight: More Than 900 Drugs o Clinical Insight on Marketed Orphan Drugs: More Than 400 Drugs o Oncology To Dominate Orphan Drug Development: 35% Share o FDA & EMA Regulations For Orphan Drugs o Orphan Drug Designation Criteria

All 5 Releases


More Releases for CNS

2019-2034 Global CNS Therapeutics Market Report & Insights
Global CNS Therapeutics Market covers therapies for a broad range of central nervous system disorders. As of 2024, the market was valued at approximately USD 128.89 billion and is expected to reach around USD 278.45 billion by 2034, expanding at a healthy compound annual growth rate (CAGR) of 7.72% robust compound annual growth rate (CAGR) of 7.67%. This growth reflects increasing prevalence of neurological and mental health conditions, advancements in
Neurosurgery Drug Market Accelerates With New CNS Treatment Breakthroughs
Neurosurgery Drug Market Overview The Neurosurgery Drug Market is projected to grow from USD 5.4 Billion in 2025 to USD 9.1 Billion by 2032, at a CAGR of 7.7% during the forecast period. Coherent Market Insights is pleased to release its latest Neurosurgery Drug Market research report, offering an in-depth analysis of the U.S. Neurosurgery Drug Market Landscape from 2025 to 2032. This report delivers reliable projections across national and regional levels,
CNS promotes craftsmanship of towel production in China
[https://youtu.be/oP-N73N0ey0] China News Service (CNS) issued a press release and a promo video here on Wednesday to promote the unique craftsmanship of towel production in Gaoyang [https://youtu.be/oP-N73N0ey0] County of Chinese northern Hebei Province. According to the CNS press release, Gaoyang is the largest hub of towel production in China, where one out of every three towels in the nation originates. More than 4200 textile enterprises are competing to flourish in this region,
Gene and Cell Therapies Targeting CNS Disorders vercoming Hurdles, Seizing Oppor …
Gene and Cell Therapies Targeting CNS Disorders Market to Record an Exponential CAGR by 2030 - Exclusive Report by InsightAce Analytic Insight Analytics Pvt. Ltd. announces the release of a market assessment report on the "Global Gene and Cell Therapies Targeting CNS Disorders Market- by Products (Gene Therapy and Cell Therapy), Indication (Amyotrophic Lateral Sclerosis, Multiple sclerosis, Spinal Cord Injury, Alzheimer, Parkinson Disease, Huntington and Other Indications), Trends, Industry Competition Analysis,
Gene Therapy in CNS Disorder Market - Unlocking the Potential of Gene Therapy: T …
Newark, New Castle, USA: The "Gene Therapy in CNS Disorder Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Gene Therapy in CNS Disorder Market: https://www.growthplusreports.com/report/gene-therapy-in-cns-disorder-market/8886 This latest report
Global CNS Therapeutics Market Opportunities and Forecast 2023-2029
Global CNS Therapeutics Market 2022 Research Report The Global CNS Therapeutics Market 2022 Research Report is a professional and in-depth study on the current state of CNS Therapeutics Market. The report provides a basic overview of the industry including definitions and classifications. The CNS Therapeutics Market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. The report discusses the various types of